We recently compiled a list of the 10 Micro and Small-Cap Firms Drive Year-to-Date Gains. In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks.

Nine micro-cap companies and one small-cap firm have been the standout performers on the stock market year-to-date, having registered whopping gains between 200 to 1,200 percent since the start of the year.

The list was based on the firms’ share price data from the companies’ closing prices on December 31—the last trading day of 2024—to February 14, 2025.

We classify micro-cap companies as those with a market capitalization below $300 million, and small-cap firms as those with a market capitalization below $1 billion.

A researcher examining a microscope in a laboratory to further their clinical-stage discovery.

Invivyd, Inc. (NASDAQ:IVVD)

Invivyd, Inc. (NASDAQ:IVVD) saw its year-to-date share prices rally by 263 percent to end Friday’s trading at $1.61 versus the 44 cents registered last December 31, as investor sentiment continues to be fueled by positive developments from its clinical trials.

On February 5, Invivyd, Inc. (NASDAQ:IVVD)—a pharmaceutical company with a $192.58-million market capitalization—registered its highest price for the year at $2.11, representing a 376-percent surge from December 31’s price, after the company announced that its pipeline candidate, VYD2311, demonstrated promising neutralizing activity against the dominant SARS-CoV-2 variant XEC.

The result further supported the effectiveness of Invivyd, Inc. (NASDAQ:IVVD)’s monoclonal antibodies, including Pemgarda (pemivibart).

Invivyd, Inc. (NASDAQ:IVVD) officially submitted its latest findings to the Food and Drug Administration (FDA), and is expected to update the Pemgarda fact sheet for healthcare providers soon.

Overall IVVD ranks 7th on our list of the top micro and small-cap firms this year so far. While we acknowledge the potential of IVVD as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than IVVD but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

 

Disclosure: None. This article is originally published at Insider Monkey.